Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2002; Volume 30,Issue 8

Articles

  • You have access
    Pharmacokinetic-Pharmacodynamic Analysis of the Glucose-Lowering Effect of Metformin in Diabetic Rats Reveals First-Pass Pharmacodynamic Effect
    David Stepensky, Michael Friedman, Itamar Raz and Amnon Hoffman
    Drug Metabolism and Disposition August 2002, 30 (8) 861-868; DOI: https://doi.org/10.1124/dmd.30.8.861
  • You have access
    Metabolism of Tamoxifen by Recombinant Human Cytochrome P450 Enzymes: Formation of the 4-Hydroxy, 4′-Hydroxy andN-Desmethyl Metabolites and Isomerization oftrans-4-Hydroxytamoxifen
    H. Kim Crewe, Lisa M. Notley, Rebecca M. Wunsch, Martin S. Lennard and Elizabeth M. J. Gillam
    Drug Metabolism and Disposition August 2002, 30 (8) 869-874; DOI: https://doi.org/10.1124/dmd.30.8.869
  • You have access
    Kinetic Analysis of the Reactions of 4-Hydroperoxycyclophosphamide and Acrolein With Glutathione, Mesna, and Wr-1065
    Kirk A. Tacka, James C. Dabrowiak, Jerry Goodisman and Abdul-Kader Souid
    Drug Metabolism and Disposition August 2002, 30 (8) 875-882; DOI: https://doi.org/10.1124/dmd.30.8.875
  • You have access
    Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7
    J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, David R. Jones, James Eckstein, Kenneth Ruterbories, Mitchell A. Hamman, Stephen D. Hall and Steven A. Wrighton
    Drug Metabolism and Disposition August 2002, 30 (8) 883-891; DOI: https://doi.org/10.1124/dmd.30.8.883
  • You have access
    Prediction of Hepatic Clearance and Availability by Cryopreserved Human Hepatocytes: An Application of Serum Incubation Method
    Yoshihiro Shibata, Hiroyuki Takahashi, Masato Chiba and Yasuyuki Ishii
    Drug Metabolism and Disposition August 2002, 30 (8) 892-896; DOI: https://doi.org/10.1124/dmd.30.8.892
  • You have access
    Glucuronidation and Sulfation of the Tea Flavonoid (−)-Epicatechin by the Human and Rat Enzymes
    Jaya Bharathi Vaidyanathan and Thomas Walle
    Drug Metabolism and Disposition August 2002, 30 (8) 897-903; DOI: https://doi.org/10.1124/dmd.30.8.897
  • You have access
    Sex Difference in Inhibition of In Vitro Mexazolam Metabolism by Various 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors in Rat Liver Microsomes
    Michi Ishigami, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
    Drug Metabolism and Disposition August 2002, 30 (8) 904-910; DOI: https://doi.org/10.1124/dmd.30.8.904
  • You have access
    Cytochrome P450 2E1 (CYP2E1) is Essential for Acrylonitrile Metabolism to Cyanide: Comparative Studies Using CYP2E1-Null and Wild-Type Mice
    Hongbing Wang, Brian Chanas and Burhan I. Ghanayem
    Drug Metabolism and Disposition August 2002, 30 (8) 911-917; DOI: https://doi.org/10.1124/dmd.30.8.911
  • You have access
    Role of Constitutive Androstane Receptor in the In Vivo Induction of Mrp3 and CYP2B1/2 by Phenobarbital
    Hao Xiong, Kouichi Yoshinari, Kim L. R. Brouwer and Masahiko Negishi
    Drug Metabolism and Disposition August 2002, 30 (8) 918-923; DOI: https://doi.org/10.1124/dmd.30.8.918
  • You have access
    Intestinal Absorption Enhancement of the Ester Prodrug Tenofovir Disoproxil Fumarate through Modulation of the Biochemical Barrier by Defined Ester Mixtures
    J. van Gelder, S. Deferme, L. Naesens, E. De Clercq, G. van den Mooter, R. Kinget and P. Augustijns
    Drug Metabolism and Disposition August 2002, 30 (8) 924-930; DOI: https://doi.org/10.1124/dmd.30.8.924
  • You have access
    Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19
    Toshiro Niwa, Akira Kageyama, Kae Kishimoto, Yoshiyasu Yabusaki, Fumihide Ishibashi and Masanao Katagiri
    Drug Metabolism and Disposition August 2002, 30 (8) 931-936; DOI: https://doi.org/10.1124/dmd.30.8.931
  • You have access
    Identification of Metabolites of a Substance P (Neurokinin 1 Receptor) Antagonist in Rat Hepatocytes and Rat Plasma
    Cornelis E. C. A. Hop, Yanfeng Wang, Sanjeev Kumar, Maria Victoria Silva Elipe, Conrad E. Raab, Dennis C. Dean, Grace K. Poon, Carol-Ann Keohane, John Strauss, Shuet-Hing L. Chiu, Neil Curtis, Jason Elliott, Ute Gerhard, Karen Locker, Denise Morrison, Russell Mortishire-Smith, Steven Thomas, Alan P. Watt and David C. Evans
    Drug Metabolism and Disposition August 2002, 30 (8) 937-943; DOI: https://doi.org/10.1124/dmd.30.8.937
  • You have access
    Phenol Sulfotransferase, ST1A3, as the Main Enzyme Catalyzing Sulfation of Troglitazone in Human Liver
    Wataru Honma, Miki Shimada, Hironobu Sasano, Shogo Ozawa, Masaaki Miyata, Kiyoshi Nagata, Toshihiko Ikeda and Yasushi Yamazoe
    Drug Metabolism and Disposition August 2002, 30 (8) 944-949; DOI: https://doi.org/10.1124/dmd.30.8.944
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 30 (8)
Drug Metabolism and Disposition
Vol. 30, Issue 8
1 Aug 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics